Champions Oncology Inc (CSBR)

Finanzdaten der Champions Oncology Inc-Aktie (CSBR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.85% 12.02	11.57	12.56	13.07	12.77
Cost Of Revenue	18.60% 7.849	6.618	7.684	7.338	7.699
Gross Profit	15.84% 4.17	4.955	4.877	5.733	5.074
Operating Expenses	2.36% 6.747	6.91	7.429	8.254	7.532
Benefits Costs and Expenses	6.64% 14.54	13.63	15.10	15.61	15.20
Costs And Expenses	6.64% 14.54	13.63	15.10	15.61	15.20
Depreciation and Amortization	0.62% 0.481	0.484	0.445	0.583	0.575
Operating Income/Loss	31.82% -2.577	-1.955	-2.552	-2.521	-2.458
Income/Loss From Continuing Operations Before Tax	22.28% -2.519	-2.06	-2.538	-2.541	-2.422
Income Tax Expense/Benefit	0.00% 0.011	0.011	0.028	0.02	0.017
Income/Loss From Continuing Operations After Tax	22.16% -2.53	-2.071	-2.566	-2.561	-2.439
Net Income/Loss	22.16% -2.53	-2.071	-2.566	-2.561	-2.439
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.72% 13.59	13.50	13.51	0.00857	13.56
Diluted Average Shares	0.72% 13.59	13.50	13.51	0.00857	13.56
Basic Earnings Per Share	26.67% -0.19	-0.15	-0.19	-0.19	-0.18
Diluted Earnings Per Share	26.67% -0.19	-0.15	-0.19	-0.19	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-